$CBDW is pleased to issue a statement in support of Adnexus Biotechnologies Inc., following the company's recent announcement of its revolutionary Neural Temporal Fingerprinting technology for personalized health monitoring. As part of our ongoing strategic partnership, 1606 Corp. recognizes the transformative potential of Adnexus' AI-driven advancements and looks forward to the continued development of these innovative solutions. https://finance.yahoo.com/news/1606-corp-expr...;tsrc=twtr